Clinical trial management firm BioClinica has announced that TauRx Therapeutics of Singapore has signed agreements to use Trident IWR/IVR and imaging core lab solutions to support its upcoming phase III clinical trials.
TauRx Therapeutic focuses its research on therapies and diagnostics for the treatment of Alzheimer's disease and other neurodegenerative disorders. The company's primary research facilities are located in Aberdeen, U.K.
BioClinica's imaging core lab acquires, processes, and interprets medical images. TauRx will use this service to process MRI data.
